PRKDC and myeloid leukemia: To test if the increase in HDR seen in the hiPSCs was dependent on the cell type or enzyme used, we introduced the DNA-PKcs KR mutation in human embryonic kidney cells (HEK293) and human immortalized myelogenous leukemia cells (K562).